Hepatocyte nuclear factor 1β suppresses canonical Wnt signaling through transcriptional repression of lymphoid enhancer-binding factor 1

被引:5
|
作者
Chan, Siu Chiu [1 ]
Hajarnis, Sachin S. [2 ,3 ]
Vrba, Sophia M. [1 ,4 ]
Patel, Vishal [2 ]
Igarashi, Peter [1 ,2 ]
机构
[1] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA
[3] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA
[4] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
HNF-1β β -catenin; LEF1; kidney; histone methylation; tissue-specific transcription factor; Wnt pathway; beta-catenin (B-catenin); transcription repressor; T-cell factor (TCF); cystic kidney disease; WNT/BETA-CATENIN; KIDNEY DEVELOPMENT; GENE-EXPRESSION; RENAL CYSTS; FACTOR-I; HNF-1-BETA; ACTIVATION; DISEASE; MECHANISMS; COMPONENTS;
D O I
10.1074/jbc.RA120.015592
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocyte nuclear factor-1 beta (HNF-1 beta) is a tissue-specific transcription factor that is required for normal kidney development and renal epithelial differentiation. Mutations of HNF-1 beta produce congenital kidney abnormalities and inherited renal tubulopathies. Here, we show that ablation of HNF-1 beta in mIMCD3 renal epithelial cells results in activation of beta-catenin and increased expression of lymphoid enhancer-binding factor 1 (LEF1), a downstream effector in the canonical Wnt signaling pathway. Increased expression and nuclear localization of LEF1 are also observed in cystic kidneys from Hnf1b mutant mice. Expression of dominant-negative mutant HNF-1 beta in mIMCD3 cells produces hyperresponsiveness to exogenous Wnt ligands, which is inhibited by siRNA-mediated knockdown of Lef1. WT HNF-1 beta binds to two evolutionarily conserved sites located 94 and 30 kb from the mouse Lef1 promoter. Ablation of HNF-1 beta decreases H3K27 trimethylation repressive marks and increases beta-catenin occupancy at a site 4 kb upstream to Lef1. Mechanistically, WT HNF-1 beta recruits the polycomb-repressive complex 2 that catalyzes H3K27 trimethylation. Deletion of the beta-catenin-binding domain of LEF1 in HNF-1 beta-deficient cells abolishes the increase in Lef1 transcription and decreases the expression of downstream Wnt target genes. The canonical Wnt target gene, Axin2, is also a direct transcriptional target of HNF-1 beta through binding to negative regulatory elements in the gene promoter. These findings demonstrate that HNF-1 beta regulates canonical Wnt target genes through long-range effects on histone methylation at Wnt enhancers and reveal a new mode of active transcriptional repression by HNF-1 beta.
引用
收藏
页码:17560 / 17572
页数:13
相关论文
共 50 条
  • [11] Lymphoid enhancer-binding factor 1 (LEF-1): a favorable prognostic factor in adult acute myeloid leukemia in Egyptian patients
    Botheina Ahmed Thabet Farweez
    Nahela Ahmed Shalaby
    Doaa Ahmed Gamal Eissa
    Raghda El Sayed Abdel Monem Galal
    Nashwa El-khazragy
    Shaimaa Abdelmalik Pessar
    Egyptian Journal of Medical Human Genetics, 21
  • [12] Lymphoid Enhancer Binding Factor 1 Regulates Transcription through Gene Looping
    Yun, Kangsun
    So, Jae-Seon
    Jash, Arijita
    Im, Sin-Hyeog
    JOURNAL OF IMMUNOLOGY, 2009, 183 (08): : 5129 - 5137
  • [13] Immunohistochemical Expression of Lymphoid Enhancer-binding Factor 1 in Low-grade Endometrial Stromal Tumors
    Niu, Shuo
    Lu, Haiyan
    Li, Wencheng
    Hou, Yanjun
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2024, 43 (05) : 487 - 493
  • [14] The Prognostic and Drug-targeting Value of Lymphoid Enhancer-binding Factor-1 in Hepatocellular Carcinoma
    Guo, Ruixiang
    Dai, Huiru
    Liu, Fuweijian
    Liu, Minling
    Li, Xueying
    Li, Tingwei
    Liao, Jiehao
    Chen, Zhe-Sheng
    Liu, Yuchen
    Fang, Shuo
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2023, 18 (02) : 211 - 223
  • [15] Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia
    Jia, M.
    Zhao, H-Z
    Shen, H-P
    Cheng, Y-P
    Luo, Z-B
    Li, S-S
    Zhang, J-Y
    Tang, Y-M
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2015, 37 (05) : 631 - 640
  • [16] Lymphoid Enhancer-binding Factor-1 (LEF1) Interacts with the DNA-binding Domain of the Vitamin D Receptor
    Luderer, Hilary F.
    Gori, Francesca
    Demay, Marie B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (21) : 18444 - 18451
  • [17] Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and Wnt pathways
    Labbé, E
    Letamendia, A
    Attisano, L
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (15) : 8358 - 8363
  • [18] Expression dynamics of lymphoid enhancer-binding factor 1 in terminal Schwann cells, dermal papilla, and interfollicular epidermis
    Song, Hongzhi
    Zhao, Xu-Bo
    Chu, Qing-Song
    Zhang, Jianyu
    Gao, Lipeng
    Liao, Xin-Hua
    DEVELOPMENTAL DYNAMICS, 2023, 252 (04) : 527 - 535
  • [19] The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology
    McHugh, Kelsey E.
    Stelow, Edward B.
    Harrison, Grant P.
    Policarpio-Nicolas, Maria Luisa C.
    CANCER CYTOPATHOLOGY, 2019, 127 (11) : 700 - 707
  • [20] Novel lymphoid enhancer-binding factor 1-cytoglobin axis promotes extravasation of osteosarcoma cells into the lungs
    Pongsuchart, Mongkol
    Kuchimaru, Takahiro
    Yonezawa, Sakiko
    Diem Thi Phuong Tran
    Nguyen The Kha
    Ngoc Thi Hong Hoang
    Kadonosono, Tetsuya
    Kizaka-Kondoh, Shinae
    CANCER SCIENCE, 2018, 109 (09): : 2746 - 2756